Company / Capital Returned to Shareholders
Avanos Medical, Inc. Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$3.3M
FY2025
5-year range
$3.3M / $45.5M
FY2021-FY2025
Trend
-74.2%
vs FY2024
Sector context
#90 of 103
Health Care
What the data says
Avanos Medical, Inc.'s capital returned to shareholders of $3M is lower than 87% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders has declined for 3 consecutive years, from $46M in FY2022 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +29.7%.
Declined from $19M to $3M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -58.3%
- 5-Year CAGR
- +29.7%
- 10-Year CAGR
- -
Sector benchmark
-99.5% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s capital returned to shareholders has declined for 3 consecutive years.
- 5-year CAGR of +29.7%, indicating consistent growth.
- In FY2025, capital returned to shareholders decreased 74.2% year-over-year.
- Ranks #90 out of 103 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.3M | -74.2% |
| FY2024 | $12.8M | -33.0% |
| FY2023 | $19.1M | -58.0% |
| FY2022 | $45.5M | +295.7% |
| FY2021 | $11.5M | +1177.8% |
| FY2020 | $900.0K | -75.0% |
| FY2019 | $3.6M | +300.0% |
| FY2018 | $900.0K | -64.0% |
| FY2017 | $2.5M | +177.8% |
| FY2016 | $900.0K | -10.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026